ARCHIVES

FDA Approves Lilly’s Alimta For Metastatic NSCLC

This article is from The Cancer Letter archive.

Vol. 27 No. 8 | August 27, 2004

Download PDF Visit The Full Archive

Related Articles

U.S., France Offer Carcinogenesis Program

February 13, 1981

Court Could Determine Future of Clinical Trials in Abigail Alliance Case.

February 9, 2007

BRCA Carriers Live Longer Than Those With Normal Gene

January 25, 2008

Iressa Authorization In Europe Clarifies Differences Between U.S., E.U. Standards

July 31, 2009

NCI Getting a Lot For a Little Money It Spends Overseas, International Program Director Says

June 17, 1977

Varmus Pools $13.4 M. To Fund Projects; NCI Gives $2.6 Mil.

December 9, 1994